comparemela.com

Oncopeptides Ab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oncopeptides Chief Financial Officer Holger Lembrer takes office today

/PRNewswire/ Oncopeptides AB (publ.) (NASDAQ Stockholm: ONCO), a biotech company focused on commercialization, research, and development of therapies for.

United kingdomMonica shawHolger lembrerRolf gulliksenLeadership teamEuropean unionGlobal head of corporate communicationsChief financial officerGlobal headCorporate communicationsPeptide drug candidateMarketing authorizationSmall capChief financial officer holger lembrerOncopeptides ab

Oncopeptides appoints Holger Lembrer as Chief Financial Officer

/PRNewswire/ Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat.

United kingdomMonica shawHolger lembrerErnst youngRolf gulliksenAnnika muskantorOncopeptides holger lembrerLeadership teamAssa abloyEuropean unionGlobal head of corporate communicationsNasdaq stockholmChief financial officerBusiness unitInvestor relations officerSenior auditor

Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer

/PRNewswire/ Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat.

United kingdomMonica shawRolf gulliksenOncopeptides jakob lindbergJakob lindbergEuropean unionEuropean medicines agencyGlobal head of corporate communicationsHealthcare products regulatory agencyNasdaq stockholmChief executive officerChief scientificMarketing authorizationMedical affairsPer wold olsenChief scientific officer

Oncopeptides has announced the Nomination Committee

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO). According to the principles for the appointment of the Nomination Committee in Oncopeptides AB.

United kingdomStiftelsen industrifondenPatrik sobockiRolf gulliksenStaffan lindstrandCaroline mebiusNomination committeeEuropean unionGlobal head of corporate communicationsOncopeptides nomination committeeNomination committee in oncopeptidesNasdaq stockholmGlobal headCorporate communicationsPeptide drug candidateMarketing authorization

Oncopeptides provides update on Pepaxto US marketing authorization

/PRNewswire/ Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat.

United kingdomRolf gulliksenJakob lindbergEuropean unionDrug administrationEuropean medicines agencyGlobal head of corporate communicationsHealthcare products regulatory agencyKiller engagersGlobal headCorporate communicationsPeptide drug candidateMarketing authorizationMid capNasdaq stockholmOncopeptides ab

vimarsana © 2020. All Rights Reserved.